Khb Pharma Ltd
13186136
Some Concerns
- Current liabilities exceed current assets (-10)
- 2 outstanding charges (-4)
Details
Compliance
Last accounts
28/02/2026
total exemption full
Next accounts due
30/11/2027
Confirmation statement
Last: 15/03/2026
Due 29/03/2027
Industry
Officers
Mrs Helen Bhudia
director · Since 24/06/2026
BRITISH · WALES · Age 34
Persons with Significant Control
Srb Pharma Limited
Churchgate House, 3 Church Road, Cardiff, CF14 2DX
Reg: 16737949 · England & Wales · Limited
Notified 21/01/2026
Former PSCs
Mr Kavil Bhudia
Ceased 21/01/2026
Mr Chi Kiu Chan
Ceased 26/01/2026
Mrs Helen Bhudia
Ceased 21/01/2026
Charges2 outstanding
SANTANDER UK PLC
SANTANDER UK PLC
PENTYRCH PHARMACY LIMITED AND KAVIL BHUDIA
CompanyRankvs 4374+ SIC 47730 peers32
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 28/02/2026
Net Worth
£100
Balance sheet strength
Cash
£179k
Cash in the bank
Net Current Assets
-£188k
Working capital
Current Assets
£287k
Current Liabilities
£475k
Fixed Assets
£189k
Debtors
£90k
Profit After Tax
£75k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2026 | 0.60 |
| 2025 | 0.64 |
| 2024 | 0.50 |
| 2023 | 0.48 |
Derived from filed accounts. Not audited figures.